Statin: Clinical Trials

19 trials of Statin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 unknown, 8 completed, 2 terminated. 19 Phase 2, 3 Phase 3, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 219Unknown 9, Completed 8, Terminated 2
Phase 33Unknown 3
Phase 12Completed 1, Unknown 1

Follow Statin: new trials by email Literature Review of Statin trials Research Report on Statin

Trials (filtered) newest first · largest first

All 19 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy
Statin - Solid Tumors, Ototoxicity
Phase 1 / Phase 2CompletedMinia University562024-09-012026-01-20
An Exploratory Clinical Study of Statins for Improving Chemotherapy and Maintenance in Patients With Ovarian Cancer
Statin, Sugar pill - Ovarian Cancer
Phase 2UnknownAnhui Provincial Cancer Hospital5002024-06-302024-06-21
Statin for Neuroprotection in Spontaneous Intracerebral Hemorrhage
Statin - Intracerebral Hemorrhage, Statins
Phase 2 / Phase 3UnknownCapital Medical University982021-08-062024-01-23
The Benefit of Add On DLBS1033 for Ischemic Stroke Patient
DLBS1033, Aspirin, Statin - Ischemic Stroke
Phase 2 / Phase 3UnknownDuta Wacana Christian University1802020-04-012020-06-11
Lipid-lowering Effects of Gefarnate in Statin-treated Coronary Heart Disease Patients With Residual Hypertriglyceridemia
Gefarnate, Statin - Coronary Artery Disease
Phase 2 / Phase 3UnknownFirst Affiliated Hospital of Harbin Medical University702019-09-012020-07-30
Effect of Berberine for Endothelial Function and Intestinal Microflora in Patients With Coronary Artery Disease
Berberine, Aspirin, Clopidogrel - Stable Coronary Artery Disease, Percutaneous Coronary Intervention
Phase 1 / Phase 2UnknownPeking Union Medical College Hospital242019-06-212020-06-16
Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence
Pravastatin Pill, Placebo Oral Tablet - Hepatocellular Carcinoma, Liver Cirrhoses
Phase 2TerminatedCedars-Sinai Medical Center12018-09-272021-01-22
Statins for the Primary Prevention of Heart Failure in Patients Receiving Anthracycline Pilot Study
Atorvastatin, Placebo oral tablet - Cancer, Heart Failure
Phase 2UnknownUniversity Health Network, Toronto1122018-05-102022-02-08
Transplantation Efficacy of Autologous Bone Marrow Mesenchymal Stem Cells With Intensive Atorvastatin in AMI Patients
Atorvastatin, Intensive Atorvastatin, Low dose BMMSC - Myocardial Infarction, Stem Cell Transplantation
Phase 2UnknownYuejin Yang1242018-03-062018-01-25
Red Rice Yeast in Low-density Lipoprotein (LDL) Lowering: an Efficacy Study
Red Rice Yeast Extract, Statin - Dyslipidemias, LDL Hyperlipoproteinemia
Phase 2UnknownSaint-Joseph University402018-02-072019-10-08
Pilot Study To Assess CAT-2003 in Patients With Hyperlipidemia
CAT-2003, Placebo, Statin - Dyslipidemia, Hypercholesterolemia
Phase 2CompletedCatabasis Pharmaceuticals992013-07-012016-07-28
A Study of LY3015014 in Participants With High Cholesterol
LY3015014, Placebo, Statin - Hypercholesterolemia
Phase 2CompletedEli Lilly and Company5272013-06-012019-09-18
A Multiple Dose Study of PF-04950615 (RN316) in Subjects on High Doses of Statins
Placebo, Statin, PF-04950615 (RN316) - Hypercholesterolemia, Dyslipidemia
Phase 2CompletedPfizer932011-07-012017-10-11
Strengthening Transplantation Effects of Bone Marrow Mononuclear Cells With Atorvastatin in Myocardial Infarction
Atorvastatin and mononuclear cells transplantation - Myocardial Infarction, Stem Cell Transplantation
Phase 2CompletedChinese Academy of Medical Sciences, Fuwai Hospital1002009-01-012018-01-25
Comparison of SLx-4090 Combined With Statin Therapy Versus Statin Alone in Reducing LDL-C in Patients With Hyperlipidemia
SLx-4090, Placebo, Statin - Hyperlipidemia
Phase 2CompletedResponse Pharmaceuticals1332009-01-012023-11-18
Efficacy Study of p38 Kinase Inhibitor to Treat Patients With Atherosclerosis
Placebo, BMS-582949, Atorvastatin - Vascular Diseases
Phase 2CompletedBristol-Myers Squibb722008-12-012015-12-07
Lovastatin: Immunomodulatory Value Evaluation
Lovastatin, placebo - HIV Seropositivity
Phase 2CompletedUniversidad de Antioquia1122008-08-012011-10-04
Systemic Inflammation and Obstructive Sleep Apnea Syndrome: Effect of Atorvastatin
Atorvastatin treatment, CPAP device, sham CPAP treatment - Obstructive Sleep Apnea Syndrome
Phase 2TerminatedUniversity Hospital, Grenoble542008-05-012013-09-24
Statins and Breast Cancer Biomarkers
Atorvastatin, Placebo - Breast Cancer
Phase 2UnknownUniversity of Vermont1002005-01-012010-02-11

Conditions studied

Dyslipidemias (3)  ·  Hypercholesterolemia (3)  ·  Myocardial Infarction (2)  ·  Breast Neoplasms (1)  ·  Carcinoma, Hepatocellular (1)  ·  Cardiotoxicity (1)  ·  Cerebral Hemorrhage (1)  ·  Coronary Artery Disease (1)  ·  HIV Seropositivity (1)  ·  Heart Failure (1)  ·  Hyperlipidemias (1)  ·  Hypertriglyceridemia (1)  ·  Ischemic Stroke (1)  ·  Neoplasms (1)  ·  Ototoxicity (1)

Sponsors

Anhui Provincial Cancer Hospital (1)  ·  Bristol-Myers Squibb (1)  ·  Capital Medical University (1)  ·  Catabasis Pharmaceuticals (1)  ·  Cedars-Sinai Medical Center (1)  ·  Chinese Academy of Medical Sciences, Fuwai Hospital (1)  ·  Duta Wacana Christian University (1)  ·  Eli Lilly and Company (1)  ·  First Affiliated Hospital of Harbin Medical University (1)  ·  Minia University (1)  ·  Peking Union Medical College Hospital (1)  ·  Pfizer (1)  ·  Response Pharmaceuticals (1)  ·  Saint-Joseph University (1)  ·  Universidad de Antioquia (1)

Countries

United States (7)  ·  China (5)  ·  Canada (4)  ·  Colombia (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Egypt (1)  ·  France (1)  ·  Indonesia (1)  ·  Japan (1)  ·  Lebanon (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Puerto Rico (1)  ·  Switzerland (1)

Top investigators

Carlos J Montoya, MD, PhD (1)  ·  Dalia F. Mohammed Fahim, PhD (1)  ·  Eitan Amir (1)  ·  Eman M. Sadek, PhD (1)  ·  Fabian A Jaimes, MD, PhD (1)  ·  Fatma M. Mady, Professor (1)  ·  Maria T Rugeles, PhD (1)  ·  Marie E Wood, MD (1)  ·  Marouan Zoghbi (1)  ·  Nada H. Ali Sholkami, PhD (1)  ·  Noha H. Helmy, Masters (1)  ·  Paaladinesh Thavendiranathan (1)

Results publications

PMID 19538732, PMID 23085245, PMID 25221387, PMID 25913664, PMID 26567858, PMID 28181260, PMID 29037448, PMID 31829095, PMID 32393654, PMID 37120736, PMID 37994400, PMID 38908848

NIH funding

R01CA218486 (1)